HBM Healthcare Investments AG

HBM Healthcare Investments AG is a Swiss-based investment company specializing in the global healthcare sector. Established in 2001, it operates as a closed-ended investment firm with a permanent capital structure. The company's core purpose is to achieve long-term capital growth by maintaining a diversified portfolio of both private and public healthcare companies across North America, Asia, and Europe. Its holdings span a broad range of segments, including biotechnology, human medicine, medical technology, diagnostics, and health IT. HBM Healthcare Investments AG typically focuses on innovative growth companies, often entering during the clinical proof-of-concept stage and supporting them through significant development milestones. The company is known for leveraging its dedicated private and public equity teams and a robust industry network to drive portfolio value. With notable exposure to emerging healthcare trends and a track record of over 60 IPOs or trade sales since 2010, HBM Healthcare Investments AG plays a significant role in financing and accelerating innovation within the healthcare industry.